60 Degrees Pharma Announces Approval of Reverse Stock Split Ratio to Maintain Nasdaq Listing
ByAinvest
Thursday, Jan 15, 2026 8:08 am ET1min read
SXTP--
60 Degrees Pharmaceuticals has announced a 1:4 reverse stock split to comply with Nasdaq listing requirements. The split will become effective on January 20, 2026, and will affect all outstanding shares of common stock. The par value of the stock will remain unchanged at $0.0001 per share, and no fractional shares will be issued. The new CUSIP number for the stock will be 83006G500.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet